CSF-1 drops demonstrate efficacy, safety in clinical studies for treatment of presbyopia
Elad Kedar, CEO of Orasis Pharmaceuticals, provides a company update at OIS@AAO 2018 in Chicago.
Glasses versus observation for moderate hyperopia unanswered: PEDIG study
Understanding advantages, limitations of SS-OCT
AAO connects ‘Art + Science’ of ophthalmology in Chicago
Joint event to feature plenty of symposia, practice management programs, product innovations
Welcome to AAO 2017
Connect with ARVO colleagues during AAO
AAO launches IRIS Registry
The American Academy of Ophthalmology (AAO) has officially launched the Intelligent Research in Sight (IRIS) Registry, the United States’ first comprehensive eye disease and condition registry.
